Myoneurogastrointestinal encephalopathy syndrome: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
'''''Synonyms and keywords : ''''' mitochondrial neurogastrointestinal encephalopathy disease, MNGIE disease | '''''Synonyms and keywords : ''''' mitochondrial neurogastrointestinal encephalopathy disease, MNGIE disease | ||
==Overview== | ==Overview== | ||
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the digestive system and nervous system. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen with time. | Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the [[digestive system]] and [[nervous system]]. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen with time.<ref>http://ghr.nlm.nih.gov/condition/mitochondrial-neurogastrointestinal-encephalopathy-disease</ref> | ||
==Pathophysiology== | ==Pathophysiology== | ||
===Genetics=== | ===Genetics=== | ||
Mutations in the TYMP gene (previously known as ECGF1) cause this disease. This gene provides instructions for making an enzyme called thymidine phosphorylase. Thymidine is a molecule known as a nucleoside, which (after a chemical modification) is used as a building block of DNA. Thymidine phosphorylase breaks down thymidine into smaller molecules, which helps regulate the level of nucleosides in cells. | [[Mutations]] in the TYMP gene (previously known as ECGF1) cause this disease. This gene provides instructions for making an enzyme called thymidine phosphorylase. Thymidine is a molecule known as a nucleoside, which (after a chemical modification) is used as a building block of DNA. Thymidine phosphorylase breaks down thymidine into smaller molecules, which helps regulate the level of nucleosides in cells. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The prevalence of the disease is unknown. About 70 people with this disorder have been reported. | The prevalence of the disease is unknown. About 70 people with this disorder have been reported. | ||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
* Satiety | * [[Satiety]] after eating only a small amount | ||
* Dysphagia | * [[Dysphagia]] | ||
* Nausea and vomiting | * [[Nausea]] and [[vomiting]] | ||
* Odynophagia | * [[Odynophagia]] | ||
* Abdominal pain | * [[Abdominal pain]] | ||
* Diarrhea and intestinal blockage. | * [[Diarrhea]] and intestinal blockage. | ||
These gastrointestinal problems lead to extreme weight loss and reduced muscle mass (cachexia). | These gastrointestinal problems lead to extreme [[weight loss]] and reduced muscle mass ([[cachexia]]). | ||
===Physical Examination=== | ===Physical Examination=== | ||
====Eyes==== | ====Eyes==== | ||
* Ptosis | * [[Ptosis]] | ||
* Opthalmoplegia | * [[Opthalmoplegia]] | ||
====Neurologic Examination==== | ====Neurologic Examination==== | ||
* Hearing loss | * [[Hearing loss]] | ||
* Tingling, numbness, and weakness in their limbs | * Tingling, numbness, and weakness in their limbs | ||
* Peripheral neuropathy, particularly in the hands and feet. | * [[Peripheral neuropathy]], particularly in the hands and feet. | ||
====MRI==== | ====MRI==== | ||
Leukoencephalopathy, which is the deterioration of a type of brain tissue known as white matter, is a hallmark of MNGIE disease. These changes in the brain can be seen with magnetic resonance imaging (MRI). | [[Leukoencephalopathy]], which is the deterioration of a type of brain tissue known as white matter, is a hallmark of MNGIE disease. These changes in the brain can be seen with magnetic resonance imaging (MRI). | ||
==References== | ==References== |
Latest revision as of 21:36, 29 July 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords : mitochondrial neurogastrointestinal encephalopathy disease, MNGIE disease
Overview
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the digestive system and nervous system. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen with time.[1]
Pathophysiology
Genetics
Mutations in the TYMP gene (previously known as ECGF1) cause this disease. This gene provides instructions for making an enzyme called thymidine phosphorylase. Thymidine is a molecule known as a nucleoside, which (after a chemical modification) is used as a building block of DNA. Thymidine phosphorylase breaks down thymidine into smaller molecules, which helps regulate the level of nucleosides in cells.
Epidemiology and Demographics
The prevalence of the disease is unknown. About 70 people with this disorder have been reported.
Diagnosis
History and Symptoms
- Satiety after eating only a small amount
- Dysphagia
- Nausea and vomiting
- Odynophagia
- Abdominal pain
- Diarrhea and intestinal blockage.
These gastrointestinal problems lead to extreme weight loss and reduced muscle mass (cachexia).
Physical Examination
Eyes
Neurologic Examination
- Hearing loss
- Tingling, numbness, and weakness in their limbs
- Peripheral neuropathy, particularly in the hands and feet.
MRI
Leukoencephalopathy, which is the deterioration of a type of brain tissue known as white matter, is a hallmark of MNGIE disease. These changes in the brain can be seen with magnetic resonance imaging (MRI).